Brought to you by 
Celera Diagnostics, Abbott Labs in diagnostics deal
30 Jul 2002
Executive Summary
Abbott Laboratories and Celera Diagnostics (JV between Applied Biosystems and Celera Genomics) will collaborate in the development and marketing of new in vitro molecular diagnostics to detect, monitor, and select appropriate therapy for a variety of conditions, such as infectious, cardiovascular, and autoimmune diseases, CNS disorders, and cancer.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Celera Diagnostics, Abbott Labs in diagnostics deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice